Home › Funds › TANG CAPITAL MANAGEMENT LLC › AVIR
TANG CAPITAL MANAGEMENT LLC position in AVIR
ATEA PHARMACEUTICALS INC · Health Care
TANG CAPITAL MANAGEMENT LLC reported holding 4,814,700 shares of AVIR (ATEA PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$22.4M, representing 1.02% of its reported portfolio and ranking #23 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed AVIR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How TANG CAPITAL MANAGEMENT LLC's AVIR position evolved
TANG CAPITAL MANAGEMENT LLC first disclosed a stake in AVIR in Q3 2023 at 3,600,000 shares (US$10.8M). The position peaked in Q1 2026 at 4,814,700 shares, worth US$25.9M. Across 12 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 4,814,700 shares valued at US$22.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.60M | $10.80M | New |
| Q4 2023 | 4.08M | $12.43M | Add |
| Q1 2024 | 4.08M | $16.47M | Hold |
| Q2 2024 | 4.48M | $14.82M | Add |
| Q3 2024 | 4.61M | $15.43M | Add |
| Q4 2024 | 4.79M | $16.04M | Add |
| Q1 2025 | 4.80M | $14.35M | Hold |
| Q2 2025 | 4.89M | $17.60M | Add |
| Q3 2025 | 4.83M | $14.00M | Reduce |
| Q4 2025 | 4.81M | $17.19M | Hold |
| Q1 2026 | 4.81M | $25.90M | Hold |
| Q2 2026 | 4.81M | $22.39M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AVIR and 13F data
AVIR (ATEA PHARMACEUTICALS INC) is a Health Care company. 31 other funds we track also report a position in AVIR — the largest reported positions include BML Capital Management, LLC (US$32.3M), Bain Capital Life Sciences Investors, LLC (US$9.7M), Rosalind Advisors, Inc. (US$5.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AVIR
- BML Capital Management, LLC 6.95M sh · $32.33M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 2.08M sh · $9.65M · Q2 2026
- Rosalind Advisors, Inc. 1.07M sh · $4.98M · Q2 2026
- Royal Palms Capital LLC 71.13K sh · $2.82M · Q3 2026
- CM Management, LLC 355.00K sh · $1.65M · Q2 2026
More on TANG CAPITAL MANAGEMENT LLC
FAQ
How long has TANG CAPITAL MANAGEMENT LLC held AVIR?
TANG CAPITAL MANAGEMENT LLC has disclosed AVIR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is TANG CAPITAL MANAGEMENT LLC's current position in AVIR?
As of Q2 2026, TANG CAPITAL MANAGEMENT LLC holds 4.81M shares of AVIR (ATEA PHARMACEUTICALS INC), valued at $22.39M, representing 1.02% of its reported portfolio and ranking #23.
Has TANG CAPITAL MANAGEMENT LLC been buying or selling AVIR?
In the latest 13F filing (Q2 2026), TANG CAPITAL MANAGEMENT LLC held unchanged its position in AVIR. The position peaked in Q1 2026 at 4.81M shares.
Which other funds hold AVIR?
Other major institutional holders of AVIR include BML Capital Management, LLC, Bain Capital Life Sciences Investors, LLC, Rosalind Advisors, Inc., among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.